TW201307561A - 使用凝膠滲透層析法純化病毒之方法 - Google Patents

使用凝膠滲透層析法純化病毒之方法 Download PDF

Info

Publication number
TW201307561A
TW201307561A TW101115116A TW101115116A TW201307561A TW 201307561 A TW201307561 A TW 201307561A TW 101115116 A TW101115116 A TW 101115116A TW 101115116 A TW101115116 A TW 101115116A TW 201307561 A TW201307561 A TW 201307561A
Authority
TW
Taiwan
Prior art keywords
virus
buffer
gel permeation
permeation chromatography
buffered saline
Prior art date
Application number
TW101115116A
Other languages
English (en)
Chinese (zh)
Inventor
麥修C 卡非
艾利森 哈格曼
羅克斯那 卡帕迪亞
莎拉 瑟爾
Original Assignee
腫瘤防治生化科技公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 腫瘤防治生化科技公司 filed Critical 腫瘤防治生化科技公司
Publication of TW201307561A publication Critical patent/TW201307561A/zh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
TW101115116A 2011-04-29 2012-04-27 使用凝膠滲透層析法純化病毒之方法 TW201307561A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29

Publications (1)

Publication Number Publication Date
TW201307561A true TW201307561A (zh) 2013-02-16

Family

ID=47067091

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101115116A TW201307561A (zh) 2011-04-29 2012-04-27 使用凝膠滲透層析法純化病毒之方法

Country Status (15)

Country Link
US (1) US20120273424A1 (cg-RX-API-DMAC10.html)
EP (1) EP2702147B1 (cg-RX-API-DMAC10.html)
JP (1) JP6029651B2 (cg-RX-API-DMAC10.html)
KR (2) KR20140024406A (cg-RX-API-DMAC10.html)
CN (1) CN103492557B (cg-RX-API-DMAC10.html)
AU (1) AU2012248082B2 (cg-RX-API-DMAC10.html)
CA (1) CA2832367A1 (cg-RX-API-DMAC10.html)
DK (1) DK2702147T3 (cg-RX-API-DMAC10.html)
EA (1) EA201391605A1 (cg-RX-API-DMAC10.html)
ES (1) ES2822199T3 (cg-RX-API-DMAC10.html)
IL (1) IL228491A (cg-RX-API-DMAC10.html)
MX (1) MX337348B (cg-RX-API-DMAC10.html)
SG (1) SG194449A1 (cg-RX-API-DMAC10.html)
TW (1) TW201307561A (cg-RX-API-DMAC10.html)
WO (1) WO2012145837A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2819236A1 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Lyophilized viral formulations
MX373096B (es) * 2010-12-02 2020-04-27 Oncolytics Biotech Inc Formulaciones virales líquidas.
RS57864B1 (sr) * 2013-06-17 2018-12-31 De Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Spo Postupci za sprečavanje agregacije virusnih komponenti
CA3104392A1 (en) 2018-07-04 2020-01-09 Probiogen Ag Method for purifying an enveloped virus
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法
HUP2400154A1 (hu) * 2024-02-29 2025-09-28 Pecsi Tudomanyegyetem Elúciós oldat és tisztítási eljárás

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
DE69029765T2 (de) * 1989-07-24 1997-05-15 Bayer Ag Stabilisierung von hochgereinigten Proteinen
ES2264126T3 (es) * 1994-05-16 2006-12-16 MERCK & CO., INC. Vacunas contra el papilomavirus.
KR100918187B1 (ko) * 1998-02-17 2009-09-22 쉐링 코포레이션 바이러스를 포함하는 조성물 및 바이러스 제제의 농축방법
IL157304A0 (en) 2001-03-16 2004-02-19 Oncolytics Biotech Inc Method of extracting virus from cell culture
DE60327069D1 (de) * 2002-04-30 2009-05-20 Oncolytics Biotech Inc Verbesserte reinigungsmethode für viren
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
CA2662569C (en) * 2006-08-07 2017-01-03 Japan As Represented By Director General Of National Institute Of Infectious Diseases Process for preparing live smallpox vaccine
SG191602A1 (en) * 2007-03-12 2013-07-31 Oncolytics Biotech Inc Reoviruses having modified sequences
AU2008321016B2 (en) * 2007-11-12 2013-03-28 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
CA2819236A1 (en) * 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Lyophilized viral formulations
MX373096B (es) * 2010-12-02 2020-04-27 Oncolytics Biotech Inc Formulaciones virales líquidas.

Also Published As

Publication number Publication date
KR20190026059A (ko) 2019-03-12
AU2012248082A1 (en) 2013-05-09
EP2702147A1 (en) 2014-03-05
CA2832367A1 (en) 2012-11-01
EA201391605A1 (ru) 2014-02-28
CN103492557B (zh) 2015-07-29
IL228491A0 (en) 2013-12-31
SG194449A1 (en) 2013-12-30
WO2012145837A1 (en) 2012-11-01
CN103492557A (zh) 2014-01-01
DK2702147T3 (da) 2020-09-28
IL228491A (en) 2017-05-29
JP2014516515A (ja) 2014-07-17
ES2822199T3 (es) 2021-04-29
MX2013012627A (es) 2014-05-13
AU2012248082B2 (en) 2015-08-20
KR102151890B1 (ko) 2020-09-03
KR20140024406A (ko) 2014-02-28
US20120273424A1 (en) 2012-11-01
EP2702147B1 (en) 2020-07-15
MX337348B (es) 2016-02-29
EP2702147A4 (en) 2014-11-05
JP6029651B2 (ja) 2016-11-24

Similar Documents

Publication Publication Date Title
EP2702147B1 (en) Methods of purifying viruses using gel permeation chromatography
ES2562237T3 (es) Métodos mejorados de purificación viral
AU2003229159B2 (en) Improved viral purification methods
MX2013006169A (es) Formulaciones virales liofilizadas.
Ianiro et al. Genetic diversity of G9P [8] rotavirus strains circulating in Italy in 2007 and 2010 as determined by whole genome sequencing
HK1190431B (en) Methods of purifying viruses using gel permeation chromatography
HK1190431A (en) Methods of purifying viruses using gel permeation chromatography
EP3818150A1 (en) Method for purifying an enveloped virus
US20250346868A1 (en) Viral Extraction from Cell Culture
Estes et al. Rotaviruses: cause of vaccine-preventable disease yet many fundamental questions remain to be explored
Ndifor et al. The Prevalence of Rotavirus and Adenovirus in Children 0-5 years old Suffering from Acute Diarrhea in the University Hospital Center of Mother and Child (UHC-MC) in N’Djamena, Chad